Allergy Mix Los Angeles
NDC Package 72617-3003-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Allergy Mix Los Angeles is uses: Allergy symptom reliefFor temporary relief of symptoms due to hay feveror other respiratory allergies. Marketed by Asn, this product is identified by NDC 72617-3003.

Identification & Billing

NDC Package Code
72617-3003-2
Package Description
120 TABLET, CHEWABLE in 1 BOTTLE
Product Code
72617-3003
11-Digit Billing Format
72617300302

Clinical Specifications

Proprietary Name
Allergy Mix Los Angeles
Dosage Form
-
Usage Information
Uses: Allergy symptom reliefFor temporary relief of symptoms due to hay feveror other respiratory allergies. Runny nose,sneezing, irritated eyes, nasal congestion, itchynose and throat, sinus pain.

Regulatory & Marketing

Labeler Name
Asn
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
01-23-2019
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72617-3003-2 identifies a specific commercial package of 120 tablet, chewable in 1 bottle of Allergy Mix Los Angeles, labeled by Asn. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Asn on January 23, 2019. The current certification is valid through December 31, 2022.

How is this Asn product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72617300302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
72617-3003-2
11-Digit CMS (5-4-2)
72617-3003-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.